Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infants
Guillaume Butler‐LaporteiD, Kathryn AucklandiD, Zannatun NooriD, Mamun KabiriD, Masud AlamiD, Tommy CarstenseniD, Genevieve L. WojcikiD, Amanda Yoon-Yee ChongiD, Cristina PomillaiD, Janelle Annette NobleiD, Shana L. McDevittiD, Gaby P. SmitsiD, Susan WareingiD, Fiona R.M. van der KlisiD, Katie JM JefferyiD, Beth D. KirkpatrickiD, Sodiomon Bienvenu SirimaiD, Shabir Ahmed MadhiiD, Alison M. ElliottiD, John Brent RichardsiD, Adrian V. S. HilliD, Priya DuggaliD, PROVIDE authors, Cryptosporidiosis Birth Cohort authors, Manjinder Singh SandhuiD, , Alexander J. MentzeriD
Abstract
Hepatitis B virus (HBV) vaccine escape mutants (VEM) are increasingly described, threatening progress in control of this virus worldwide. Here we studied the relationship between host genetic variation, vaccine immunogenicity and viral sequences implicating VEM emergence. In a cohort of 1,096 Bangladeshi children, we identified human leukocyte antigen (HLA) variants associated with response vaccine antigens. Using an HLA imputation panel with 9,448 south Asian individuals DPB1*04:01 was associated with higher HBV antibody responses (p=4.5x10-30). The underlying mechanism is a result of higher affinity binding of HBV surface antigen epitopes to DPB1*04:01 dimers. This is likely a result of evolutionary pressure at the HBV surface antigen a-determinant segment incurring VEM specific to HBV. Prioritizing pre-S isoform HBV vaccines may tackle the rise of HBV vaccine evasion. One-Sentence SummaryHost genetics underlying hepatitis B vaccine response in Bangladeshi infants identifies mechanisms of viral vaccine escape, and how to prevent it.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic accessibility, not superior fitness, determines which anti-HBs antibody escape variants are selected in patients
Yingpu Yu, Eleftherios Michailidis, … Ype P. de Jong·bioRxiv·Oct 8, 2026
- Public broadly neutralizing antibodies against hepatitis B virus in individuals with elite serologic activity
Q. Wang, E. Michailidis, … M. C. Nussenzweig·bioRxiv·Mar 4, 2020
- Genetic signatures in the highly virulent subtype B HIV-1 conferring immune escape to V1/V2 and V3 broadly neutralizing antibodies
Manukumar Honnayakanahalli Marichannegowda, Georgina Agyekum, … Hongshuo Song·iSciencePeer-reviewed·Jun 7, 2025
- Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
J. Mokaya, T. I. Vasylyeva, … P. C. Matthews·bioRxiv·Oct 7, 2020
- Multiple Mechanisms of HIV-1 resistance to PGT135 in Chinese Subtype B' Slow Progressor
- Preexisting memory CD4 T cells in nÏave individuals confer robust immunity upon hepatitis B vaccination
G. Elias, P. Meysman, … B. Ogunjimi·bioRxiv·Aug 22, 2020